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Summary Several drugs have been employed for sedation during flexible fiberoptic
bronchoscopy (FOB). Clonidine attenuates stress-induced sympathoadrenal re-
sponses and has sedative properties. We investigate the effects of clonidine pre-
medication on hemodynamic and comfort parameters of patients submitted to FOB
under airway topical anesthesia only. Patients received placebo (n¼ 22; men¼ 16;
median age¼ 50.5 years) or intravenous clonidine (3 mg/kg; n¼ 20; men¼ 15;
median age¼ 46.0 years) 15min before FOB. Blood pressure (BP), heart rate (HR),
plasma norepinephrine (nor) and cortisol levels were measured before, during, and
1 h after FOB. Comfort was assessed by the examiner and by the patients using a
visual numerical scale (0–10). The placebo group showed significant increases in
systolic BP, HR, and nor levels during FOB (SBP ¼ 125mmHg 145mmHg;
HR¼ 74 bpm 85 bpm; nor ¼ 316.2 pg/dl 483.1 pg/dl), whereas clonidine group
did not display such changes. Clonidine group showed a lower frequency of cardiac
arrhythmias than the placebo group during and after FOB (supraventricular ¼
39% 50%; ventricular¼ 22% 40%). Levels of comfort were high and comparable in
both groups. We concluded that although clonidine led to a somewhat better
hemodynamic profile, it did not contribute to better comfort in this setting.
& 2004 Elsevier Ltd. All rights reserved.
Introduction
Different agents have been employed for pre-
medication and sedation during flexible fiberoptic
bronchoscopy (FOB), depending on the personal
preferences of individual operators.1,2 Most
bronchoscopists use sedative drugs before FOB in
order to reduce stress and improve comfort and
cooperation. Among a wide list of sedative drugs,
opioids and benzodiazepines, alone or in combina-
tion, are those most frequently chosen. However,
the necessity of any sedation for FOB has been
questioned due to potential complications with the
routine use of these drugs.3,4 In addition, FOB is a
brief procedure generally performed on an out-
patient basis, and the use of sedation may prolong
hospital stay and increase costs related to the
exam.
Clonidine is a centrally acting a2-agonist that
attenuates stress-induced sympathoadrenal re-
sponses, promotes intra-operative hemodynamic
stability, and reduces anesthetic requirements
during surgical procedures.5,6 Clonidine itself has
slight sedative properties.7 It has been shown that
the use of clonidine as pre-medication attenuates
the hemodynamic responses induced by flexible and
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rigid bronchoscopy.8,9 However, the usefulness of
clonidine in patients submitted to FOB without any
sedation has not been investigated.
The objective of this randomized, double-blind,
placebo-controlled study was to investigate the
effects of clonidine pre-medication on hemody-
namic, hormonal, and comfort parameters of
patients submitted to FOB under airway topical
anesthesia only.
Methods
Patients
Forty-two patients undergoing routine diagnostic
FOB were evaluated. The indications for FOB
included lung masses (38%), pulmonary infections
(31%), interstitial lung diseases (19%), and others
(12%). Patients with a history of recent myocardial
infarction, or who had used drugs with cardiovas-
cular actions, like calcium channel antagonists or
beta-blockers, during the previous week were not
studied. Patients who had been on steroids during
the past month were also excluded. The research
protocol was approved by the Institution Ethics
Committee, and written consent was obtained from
each patient immediately before the procedure.
Procedure
Patients were admitted to the bronchoscopy suite
and, after installation of a venous access and
monitoring devices, received a verbal explanation
and were tranquilized about the procedure to be
performed. They were then allowed to rest for
30min in a quiet atmosphere, and randomized to
receive a previously coded intravenous preparation
containing placebo or clonidine (3 mg/kg, not
exceeding a total of 300 mg, a generous gift of
Cristalia Laboratories). Drug or placebo in propor-
tional volumes was diluted in 50ml of saline and
administered over a period of 15min. Next, all
patients received topical anesthesia by the admin-
istration of puffs of 4% lidocaine spray to the
oropharynx, and 2% lidocaine jelly to the nostrils.
At this point, supplemental oxygen was introduced
routinely via a nasal catheter. Additional anesthesia
was performed as the bronchoscope progressed into
the airways by instillation of 2% lidocaine aliquots
through its work channel, according to individual
patient’s requirements.
The same physician performed all examinations
by the trans-nasal route, with the patients in the
supine position, using an Olympus BF P 30 broncho-
scope (Olympuss, Tokyo). The physician and nur-
sing staff were blinded about the allocation of
patients to one of the two groups. All exams were
performed at the same time in the morning,
between 8:00 and 10:00 AM.
Measurements
Data collection was performed at three different
points: (i) immediately before drug or placebo
application (baseline conditions), (ii) at the begin-
ning of airway endoscopic examination, just after
lidocaine administration had been concluded (in-
tra-procedure conditions), and (iii) 1 h after the
procedure ended (post-procedure conditions).
Monitoring during FOB included continuous EKG by
a holter system (DMSs, S*ao Paulo), pulse oximetry
(Dixtal-2515s, S*ao Paulo) and blood pressure
measurements. Blood samples were obtained at
each point, and kept frozen for later measurements
of plasma cortisol and nor-epinephrine levels
according to a previously published methodol-
ogy.10,11
Patient comfort was assessed at the end of
bronchoscopy by the examining physician, employ-
ing a visual numerical scale ranging from 0 to 10,
the high limit representing the best degree of
tolerance. This assessment was called objective
evaluation. The subjects were also asked to express
their comfort during FOB employing a similar scale
1 h after the end of the procedure. This assessment
was called subjective evaluation.
Statistics
Results are expressed as medians and ranges of
variation. Comparisons of basal features and
frequency of cardiac arrhythmia between groups
were performed using the chi-square test.12 Com-
parisons of hemodynamic, biochemical and comfort
results for the two groups were performed using
the Mann–Whitney test. Intra-group comparisons
for data obtained at the three different points were
performed using Friedman’s test followed by Dunn’s
post hoc test when indicated. A P-valueo0.05 was
accepted as statistically significant.
Results
There were no statistically significant differences
between the two groups in terms of age, sex, type
of procedure, requirements of topical anesthesia,
and duration of the FOB (Table 1).
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Clonidine administration was well tolerated, and
only two patients showed hypotension, character-
ized by a decrease in systolic blood pressure higher
than 30% at the post-procedure point. No patient
required fluid replacement due to these episodes.
Two patients in the clonidine group fell asleep
during the post-procedure period.
The placebo group exhibited statistically signifi-
cant elevations in heart rate and systolic blood
pressure during FOB (Table 2), which were not
observed in the clonidine group. Post-procedure
systolic blood pressure and heart rate were
significantly lower than intra-procedure values in
both groups. The post-procedure diastolic blood
pressure was also significantly lower than the intra-
procedure values in the placebo group. In addition,
the clonidine group displayed a significant decrease
of both systolic and diastolic blood post-procedure
pressures in comparison to baseline values. Com-
parisons of hemodynamic results between groups
did not reach statistical significance at any time.
A substantial number of subjects in both groups
showed ventricular and supra-ventricular extra-
systolic beats before FOB (Table 3). The frequency
of these cardiac arrhythmias did not differ sig-
nificantly between groups under baseline condi-
tions or during the intra/post-procedure period.
The frequency of arrhythmias tended to be lower in
the clonidine group during and after FOB. No ST
segment changes were observed in any patient at
any time.
Plasma cortisol levels did not change significantly
over time in the placebo group, but the clonidine
group displayed post-procedure values significantly
lower than baseline (Table 2). A significant increase
in plasma nor-epinephrine levels was observed in
the placebo group during the intra-procedure
period, but not in the clonidine group. The
clonidine group also showed significantly lower
levels of nor-epinephrine during the post-proce-
dure period in comparison to baseline and intra-
procedure points.
The median objective and subjective comfort
scores were similar and elevated for both groups
(Fig. 1). There was also a high degree of agreement
between the two types of scores.
Discussion
The purpose of sedation in FOB is to improve
patient comfort for what may be an unpleasant
procedure.1,2 Sedation may also make the proce-
dure easier to perform for the bronchoscopist, and
the patient more willing to accept a possible
repeated procedure. Some placebo-controlled stu-
dies have found a beneficial effect of diazepinic
sedation during FOB, and the ‘‘BTS Guidelines to
Diagnostic Flexible Bronchoscopy’’ recommend to
offer sedation to all patients, when there is no
contraindication.2,13,14 However, the necessity for
any sedation for FOB has been questioned, and
surveys have shown that some medical centers still
perform the exam with airway topical anesthesia
only.3,4,15,16 Arguments against routine sedation
include concerns about patient safety, particularly
regarding COPD and hypoxemic subjects. The
administration of sedative drugs also requires
medical and nursing staff with specific training,
and adequate facilities for resuscitation and pro-
longed monitoring.
Clonidine is a drug known for more than 30 years
that has been increasingly used as a pre-anesthetic
agent, mainly due to its anti-sympathoadrenal
actions.5,6 Its use is associated with better intra-
operative hemodynamics and a lower incidence of
perioperative myocardial ischemic episodes during
major surgeries.17 Clonidine has also analgesic and
hypnotic properties7 and has been reported to be a
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Table 1 Patient’s characteristics.
Placebo group
(n¼ 22)
Clonidine
group (n¼ 20)
Male/Female 16/6 15/5
Age 50.5 46.0
(years) (33–70) (18–71)
FOB duration 25.0 25.0
(min) (10–40) (15–45)
Instilled lidocaine 180.0 175.0
(mg) (100–220) (120–200)
Procedures
(Times performed)
Broncoalveolar
lavage
16 16
(53.3%) (59.3%)
Bronchial
aspiration
5 4
(16.7%) (14.8%)
Bronchial brushing 3 2
(10.0%) (7.4%)
Endobronchial
biopsies
2 2
(6.7%) (7.4%)
Transbronchial
biopsies
3 3
(10.0%) (11.1%)
Bronchial
inspection only
1 0
(3.3%) (0%)
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successful substitute for sedation in short surgical
procedures performed under local anesthesia such
as ophthalmologic operations.18
Previous work has shown that the pre-operative
use of clonidine could blunt reflex tachycardia and
hypertensive responses secondary to endo-tracheal
intubation.19,20 In addition, in two studies investi-
gating the effects of clonidine premedication on
hemodynamic responses to rigid and fiberoptic
bronchoscopy, the oral use of 300 mg of clonidine
90min before microlaryngoscopy and bronchoscopy
led to smaller increases in arterial blood pressure
and to a lower incidence of ventricular arrhythmias
and evidence of myocardial ischemia than place-
bo.9 Clonidine-related side effects were not ob-
served, and the time to extubation from the end of
sedative infusion and to discharge from the
recovery room did not differ between groups.
Another study compared the effects of oral
clonidine at doses of 150 and 300 mg with placebo
given 90min before FOB.8 The patients were also
sedated with intravenous meperidine and midazo-
lam. It was found that 150 mg of oral clonidine was
well tolerated, and attenuated the blood pressure
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Table 2 Haemodynamic profile, pulse oximetry and biochemical measurements.
Baseline Intra-procedure Post-procedure
Systolic blood pressure Placebo group 125 145n 120þ
(mmHg) (n¼ 22) (90–160) (100–180) (90–180)
Clonidine group 125 110 110n,þ
(n¼ 20) (100–180) (100–190) (90–150)
Diastolic blood pressure Placebo group 80 85 80þ
(mmHg) (n¼ 22) (60–110) (60–120) (50–114)
Clonidine group 80 80 70n
(n¼ 20) (70–100) (60–90) (50–90)
Heart rate Placebo group 74 85n 74þ
(beats/min) (n¼ 22) (50–101) (58–111) (52–100)
Clonidine group 73.5 80.5 72.5þ
(n¼ 20) (50–109) (45–120) (46–100)
SaO2 Placebo group 96 96 96
(%) (n¼ 22) (93–99) (90–98) (92–99)
Clonidine group 96 96 96
(n¼ 20) (92–99) (92–99) (91–99)
Nor-epinephrine Placebo group 316.2 483.1n 320.5
(pg/ml) (n¼ 13) (132–1177) (180–1538) (103–1539)
Clonidine group 309.1 321.2 302.4n,þ
(n¼ 10) (136–667) (165–667) (103–544)
Cortisol Placebo group 11.0 10.8 9.8
(mg/dl) (n¼ 22) (2.9–31.2) (4.9–24.0) (4.9–24.4)
Clonidine group 12.4 9.9 9.2n
(n¼ 20) (3.1–23.4) (2.4–25.2) (3.3–17.4)
nPo0.05 in comparison to baseline conditions by Dunn’s test.
þPo0.05 in comparison to intra-procedure conditions by Dunn’s test.
Table 3 Frequency of arrhythmias.
Baseline Intra-procedure and post-procedure
Placebo group Clonidine group Placebo group Clonidine group
(n¼ 20) (n¼ 18) (n¼ 20) (n¼ 18)
Ventricular ectopic beats 5 4 8 4
(25%) (22%) (40%) (22%)
Supraventricular ectopic beats 4 5 10 7
(20%) (28%) (50%) (39%)
Supraventricular tachycardia 0 1 0 1
(6%) (6%)
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and heart rate increases observed during the
procedure in the placebo group. The use of
300 mg, however, was associated with longer awa-
kening times and expressive hypotension episodes
in 75% of the subjects.
The present study investigated the potential
utility of clonidine as pre-medication for FOB
performed with topical anesthesia only. We hy-
pothesized that, due to its anti-stress and anxioly-
tic properties, the drug could be an alternative to
conventional sedative agents in this setting. The
groups of patients were comparable, with no
difference in gender composition, age, duration,
or type of procedure performed between them.
We made an option to employ IV clonidine in
order to reduce the time between medicine
administration and FOB beginning. A waiting time
of 90min after oral clonidine intake would cause
operational difficulties in routine ambulatory
bronchoscopies. Although a higher frequency of
complications could be expected with the IV
preparation, we did not observe expressive side
effects or substantial hypotensive episodes related
to treatment.
We observed wide variation in the hemodynamic
results obtained for both groups at all points of the
study. Most probably due to this, the comparisons
between groups did not reach statistical signifi-
cance at any time. The results would have probably
been different if we had performed statistical
analysis employing the highest values of blood
pressure and heart rate obtained by continuous
monitoring during the procedures instead of mea-
surements recorded at pre-fixed time points.8,9
Nevertheless, analysis of the intra-group compar-
isons revealed that the events were distinct in each
group. The placebo group displayed significant
elevation of intra-procedure systolic blood pressure
and heart rate compared to baseline. Such changes
were not observed in the clonidine group. In
addition, the effect of clonidine was protracted,
since the post-procedure systolic blood pressure
values were significantly lower than those obtained
at baseline and during the procedure. As expected,
the plasma nor-epinephrine levels accompanied the
systolic blood pressure changes in both groups.
Cardiac arrhytmias are a frequent finding during
FOB. A classical study described an incidence of
32% and 20%, respectively, for supra-ventricular
and ventricular disorders during the procedure.21 In
the present study, we found an even higher
frequency of supra- and ventricular ectopic beats.
Although there were no statistically significant
differences in the frequency of cardiac arrhythmias
between groups before, during or after FOB, we
could observe a favorable trend with the use of
clonidine. The incidence of supra-ventricular and
ventricular ectopic beats during and after the
procedure was lower in the clonidine group than
in the placebo group. Therefore, the present
results indicate that pre-medication with clonidine
in patients submitted to FOB under no sedation
slightly contributed to a better hemodynamic
profile.
Plasma cortisol levels have been traditionally
employed as a measurement of the stress-induced
response to surgical proceedings. Significant in-
creases in cortisol have been described during FOB
performed under topical anesthesia.22 These in-
creases were higher in patients who reported more
discomfort during the procedure. The cortisol
elevations were abolished by the administration
of diazepam just before examination.22 The pre-
sent study did not find significant differences in
plasma cortisol levels between groups at any time.
Cortisol levels tended to drop over the different
sampling times in both groups. Clonidine use led to
a significant decrease in post-procedure plasma
cortisol in comparison to baseline levels. These
results show that the hormonal stress response
associated with FOB performed with no sedation
was of little amount, and that clonidine use had
only a minimal influence on it. However, as all
bronchoscopies were performed early in the day,
our results may have been influenced by the
physiological fall of cortisol levels observed over
the morning.
Patients of both groups were asked to express
their degree of comfort during FOB using a visual
numerical scale at the end of the observation
period. Both groups reported high median scores of
comfort during examination. There was also agree-
ment between patients’ subjective evaluation and
objective scores given by the examiner at the end
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Figure 1 Objective and subjective comfort scores for
patients treated with placebo or clonidine. Horizontal
lines represent median values.
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of the procedure. It is also interesting to note that
both groups required the same amount of instilled
lidocaine for anesthesia and that the results related
to comfort agreed, in general, with the plasma
cortisol findings. Therefore, the data clearly show
that FOB performed without sedation, and under
adequate topical anesthesia, can be well tolerated
by the patients. Although previous papers have
reported similar results, we believe that the initial
conversation about the proceedings to be done and
the half-hour rest period in a quiet atmosphere
must have significantly reduced early psychological
tension and stress among our patients.3,23–25 It has
already been shown that a high degree of anxiety
before bronchoscopy is correlated with poor toler-
ance to the exam.14 In addition, since most of the
people attended at our University Hospital are from
the low-income population, we may not completely
exclude the potential influence of social and
cultural factors on patients’ answers. It is worth
also to emphasize that, all exams were performed
by the same highly skilled and experienced physi-
cian. Whatever the explanations may be, since FOB
was so well tolerated by the placebo group, the
administration of clonidine did not add any advan-
tage regarding patient comfort.
In conclusion, the use of IV clonidine as pre-
medication for FOB was well tolerated, and
contributed to a somewhat better hemodynamic
profile during and after examination. Fiberoptic
bronchoscopy performed without sedation, under
airway anesthesia only, was well accepted by the
patients, and the use of clonidine did not add to
comfort in such circumstances. We believe that the
present results do not support the routine use of
clonidine as a pre-anesthetic drug before FOB.
References
1. Matot I, Kramer MR. Sedation in outpatient bronchoscopy.
Respir Med 2000;94:1145–53.
2. Honeybourne D, Babb J, Brewin A, et al. British Thoracic
Society guidelines on diagnostic flexible bronchoscopy.
Thorax 2001;56(Suppl SI):i1–21.
3. Hatton MQF, Allen MB, Vathenen AS, et al. Does sedation help
in fibre-optic bronchoscopy? Br Med J 1994;309:1206–7.
4. Thomas G, McBeth C. Sedation in fibre-optic bonchoscopy. Br
Med J 1995;310:872–3.
5. Maze M, Tranquilli W. Alpha-2 adrenoreceptor agonist:
defining the role in clinical anesthesia. Anesthesiology
1991;74:581–605.
6. Aantaa R, Scheinin M. Alpha-2 adrenergic agents in
anaesthesia. Acta Anaesth Scand 1993;37:433–48.
7. Hossmann V, Maling TJ, Hamilton CA, et al. Sedative and
cardiovascular effects of clonidine and nitrazepan. Clin
Pharmacol Ther 1980;28:167–76.
8. Matot I, Kuras Y, Kramer MR. Effect of clonidine premedica-
tion on haemodynamic responses to fibreoptic bronchoscopy.
Anaesthesia 2000;55:260–87.
9. Matot I, Sichel JY, Yofe V, et al. The effect of clonidine
premedication on hemodynamic responses to microlaryngo-
scopy and rigid bronchoscopy. Anesth Analg 2000;91:
828–33.
10. Musso NR, Vergassola C, Pende A, et al. Measurement
of conjugated catecholamines in human plasma: a low
cost HPLC-ECD method. J Liquid Chromat 1991;14:
3695–6.
11. Calixto C, Martinez FE, Jorge SM, et al. Correlation between
plasma and salivary cortisol levels in pre-term infants.
J Pediatr 2002;140:116–8.
12. Matthews DE, Farewell VT. Using and understanding medical
statistics, 3rd ed. Karger: Basel; 1996, p. 245.
13. Maguire GP, Rubinfield AR, Trembath PW, et al. Patients
prefer sedation for fibreoptic bronchoscopy. Respirology
1998;3:81–5.
14. Putinati S, Ballerin L, Corbetta L, et al. Patient satisfaction
with conscious sedation for bronchoscopy. Chest 1999;115:
1437–40.
15. Prakash UBS, Offord KP, Stubbs SE. Bronchoscopy in North
America: the ACCP survey. Chest 1991;100:1668–75.
16. McLean AN, Semple PD !A, Francklin DH, et al. The Scottish
multi-center prospective study of bronchoscopy for bron-
chial carcinoma and suggested audit standards. Respir Med
1998;92:1110–5.
17. Stuhmeier KD, Mainzer B, Cierpka J, et al. Small dose of
clonidine reduces the incidence of intraoperative myocar-
dial ischemia in patients having vascular surgery. Anesthe-
siology 1996;85:706–12.
18. Weindler J, Kiefer RT, Rippa A, et al. Low-dose oral clo-
nidine as premedication before intraocular surgery in
retrobulbar anesthesia. Eur J Ophthalmol 2000;10:
248–56.
19. Zalunardo MP, Zollinger A, Spahn DR, et al. Effect of
intravenous and oral clonidine on hemodynamic and
plasma-cathecolamine response due to endotracheal intu-
bation. J Clin Anesth 1997;9:143–7.
20. Mikawa K, Maekawa N, Nishina K, et al. Efficacy of oral
clonidine premedication in children. Anesthesiology
1993;79:926–31.
21. Katz AS, Michelson EL, Stawicki J, et al. Cardiac arrythmias.
Frequency during fiberoptic bronchoscopy and correlation
with hypoxemia. Arch Intern Med 1981;141:603–6.
22. Wesseling H, Edens ET. Effect of premedication on stress and
plasma cortisol in patients bronchoscoped under local
anaesthesia. Eur J Pharmacol 1975;8:323–6.
23. Pearce SJ. Fibreoptic bronchoscopy: is sedation necessary ?
Br Med J 1980;281:779–80.
24. Rees PJ, Hays JG, Webb JR. Pre medication for fibreoptic
bronchoscopy. Thorax 1983;38:624–7.
25. Colt HG, Morris JF. Fibreoptic bronchoscopy without seda-
tion: retrospective study. Chest 1990;98:1327–30.
ARTICLE IN PRESS
Clonidine as a pre-anesthetic agent 751
